
A Prescription for Change: The Looming Crisis in Drug Development - Paperback
$39.99
Out of Stock
This product is currently out of stock. Enter your email address below to be notified once the product is back in stock
Availability:Out of StockContributor:Michael KinchSeries:The Luther H. Hodges Jr. and Luther H. Hodges Sr. Business, Entrepreneurship, and Public PPublish date:3/1/2018Pages:352
Languages:EnglishPublisher:University of North Carolina PressISBN-13:9781469647579ISBN-10:1469647575UPC:9781469647579Book Category:MedicalBook Subcategory:Biotechnology, Pharmacology, PharmacySize:9.21 x 6.14 x 0.79 inchesWeight:1.1905Product ID:SC4MVQYP1N
The introduction of new medicines has dramatically improved the quantity and quality of individual and public health while contributing trillions of dollars to the global economy. In spite of these past successes -- and indeed because of them -- our ability to deliver new medicines may be quickly coming to an end. Moving from the beginning of the twentieth century to the present, A Prescription for Change reveals how changing business strategies combined with scientific hubris have altered the way new medicines are discovered, with dire implications for both health and the economy.
To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come.
To explain how we have arrived at this pivotal moment, Michael Kinch recounts the history of pharmaceutical and biotechnological advances in the twentieth century. Kinch relates stories of the individuals and organizations that built the modern infrastructure that supports the development of innovative new medicines. He shows that an accelerating cycle of acquisition and downsizing is cannibalizing that infrastructure Kinch demonstrates the dismantling of the pharmaceutical and biotechnological research and development enterprises could also provide opportunities to innovate new models that sustain and expand the introduction of newer and better breakthrough medicines in the years to come.
Languages:EnglishPublisher:University of North Carolina PressISBN-13:9781469647579ISBN-10:1469647575UPC:9781469647579Book Category:MedicalBook Subcategory:Biotechnology, Pharmacology, PharmacySize:9.21 x 6.14 x 0.79 inchesWeight:1.1905Product ID:SC4MVQYP1N
Michael Kinch is associate vice chancellor and director of the Center for Research Innovation in Biotechnology at Washington University in St. Louis.
Publisher: University of North Carolina Press
Contributor(s)
Author
Free shipping on orders over $75. Standard shipping takes 3-7 business days. Returns accepted within 30 days of purchase.
